Suchergebnisse - Yuejun Han

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer von Shiya Yao, Yuejun Han, Mengxiang Yang, Ketao Jin, Huanrong Lan

Volltext

Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance von Mengxiang Yang, Zhihui Dai, Yuejun Han, Yijing Shen, Jianping Wang

Volltext

Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment von Shiya Yao, Yuejun Han, Mengxiang Yang, Ketao Jin, Huanrong Lan

Volltext

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery? von Shiya Yao, Huanrong Lan, Yuejun Han, Chunsen Mao, Mengxiang Yang, Xuan Zhang, Ketao Jin

Volltext

Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-ar... von Yuejun Han, Qiyue Wang, Yinqi Chen, Hui Wu, Tongshuo Wu, Dongdong Huang, Haiping Jiang

Volltext

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy von Hui Wu, Wenzhi Shu, Yongfeng Ding, Qiong Li, Ning Li, Qiyue Wang, Yinqi Chen, Yuejun Han, Dongdong Huang, Haiping Jiang

Volltext

Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration von Hui Wu, Qi Jiang, Xiaodan Li, Peng Ye, Aizemaiti Rusidanmu, Ning Li, Xiaodong Teng, Qiyue Wang, Yinqi Chen, Dongdong Huang, Yuejun Han, Bingnan Wang, Wenhong Yu, Jian Tao, Jian Ruan, Haiping Jiang

Volltext